Edition:
United States

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

69.51USD
22 May 2017
Change (% chg)

$1.11 (+1.62%)
Prev Close
$68.40
Open
$68.56
Day's High
$69.58
Day's Low
$68.44
Volume
130,487
Avg. Vol
235,774
52-wk High
$73.46
52-wk Low
$56.64

RMD.N

Chart for RMD.N

About

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD),... (more)

Overall

Beta: 0.82
Market Cap(Mil.): $9,700.44
Shares Outstanding(Mil.): 141.82
Dividend: 0.33
Yield (%): 1.93

Financials

  RMD.N Industry Sector
P/E (TTM): 29.15 44.67 17.37
EPS (TTM): 2.35 -- --
ROI: 12.73 7.68 -5.89
ROE: 18.92 12.62 -5.30

ResMed withdraws U.S. trade complaint against Fisher & Paykel Healthcare

WELLINGTON Health appliance firm ResMed Inc has dropped a complaint against New Zealand's Fisher & Paykel Healthcare at the U.S. International Trade Commission (USITC), Fisher & Paykel said on Wednesday.

May 17 2017

BRIEF-Resmed plans to renew its patent infringement case against Fisher & Paykel

* Statement by ResMed on plans to renew its patent infringement case against Fisher & Paykel

May 17 2017

ResMed withdraws U.S. trade complaint against Fisher & Paykel Healthcare

WELLINGTON Health appliance firm ResMed Inc has dropped a complaint against New Zealand's Fisher & Paykel Healthcare at the U.S. International Trade Commission (USITC), Fisher & Paykel said on Wednesday.

May 16 2017

ResMed withdraws U.S. trade complaint against Fisher & Paykel Healthcare

WELLINGTON, May 17 Health appliance firm ResMed Inc has dropped a complaint against New Zealand's Fisher & Paykel Healthcare at the U.S. International Trade Commission (USITC), Fisher & Paykel said on Wednesday.

May 16 2017

BRIEF-Resmed Q3 gaap earnings per share $0.62

* Resmed Inc. Announces results for the third quarter of fiscal year 2017

Apr 27 2017

BRIEF-ResMed provides data on patients with untreated sleep apnea

* New resmed-sponsored study shows promising treatment option for patients with untreated central sleep apnea Source text for Eikon: Further company coverage:

Apr 06 2017

BRIEF-ResMed reports Q2 earnings per share $0.54

* Announces results for the second quarter of fiscal year 2017

Jan 23 2017

BRIEF-Resmed and BMC/3B Medical settle global litigation

* Resmed Inc - Settlement did not include an admission of liability or wrongdoing by any party

Jan 20 2017

BRIEF-FDA clears world's smallest CPAP, ResMed AirMini

* FDA clears world's smallest CPAP, ResMed AirMini Source text for Eikon: Further company coverage:

Jan 09 2017

Fisher & Paykel wins German court case against ResMed

WELLINGTON Fisher & Paykel Healthcare Corporation Ltd said on Friday a German court has overturned both preliminary injunctions granted to ResMed Inc, which had taken legal action against the New Zealand-based medical device maker.

Dec 01 2016

More From Around the Web

Earnings vs. Estimates